Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
A product is termed as biosimilar product, if it is a biological product with similar characteristics as that of a reference biological product, which possesses approval from agencies such as FDA. There would not be any major clinical difference in effectiveness and safety as that of reference product. Biosimilar products are made of complex molecules with high molecular weight produced through genetic engineering in living cells. Biologics drugs are costlier than respective chemical drugs. Biosimilar drugs can save around 30 to 40 % in terms of price relative to the respective biologics drugs. Biosimilars are useful for the treatment of illnesses such as anemia, autoimmune diseases, cancer, diabetes, growth hormone deficiencies, hematological diseases, kidney failure, rheumatoid arthritis and others. For the manufacturing of biosimilars, manufacturers have to develop environments that are ideal for the living cells, which remain sensitive to environmental conditions. Moreover, they need to develop distinctive process to entice the living cells for producing similar outcome to a prevalent biological treatment. The substitution of biological drugs with biosimilar drugs can save lot of money for public health care sector and patients. The regulatory authorities in developed nations are promoting biosimilar products.
This report elaborates on the current development of the Biosimilar industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Novartis
Allergan plc
BIOCAD
Coherus BioSciences
Reliance Life Sciences
Boehringer Ingelheim
Pfizer
BioXpress Therapeutics
Celltrion
Biocon
Genor BioPharma
Intas Pharmaceuticals Limited
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Human Growth Hormones
Monoclonal Antibodies
Insulin
Peptides
Erythropoietin
Others
Application:
Oncology
Chronic and Autoimmune Diseases
Growth Hormone Deficiency
Infectious Diseases
Others
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Biosimilar Industry Overview
-
1.1.1 Biosimilar Market Scope and Market Segments
-
1.1.2 Biosimilar Industry Characteristics
-
1.1.3 Global and China Biosimilar Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Biosimilar Production Value and Growth Rate (2017-2028)
-
1.2 Global Biosimilar Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Human Growth Hormones
-
1.2.2 Monoclonal Antibodies
-
1.2.3 Insulin
-
1.2.4 Peptides
-
1.2.5 Erythropoietin
-
1.2.6 Others
-
1.3 Global Biosimilar Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Oncology
-
1.3.2 Chronic and Autoimmune Diseases
-
1.3.3 Growth Hormone Deficiency
-
1.3.4 Infectious Diseases
-
1.3.5 Others
-
1.4 Market Analysis by Region
-
1.4.1 North America Biosimilar Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Biosimilar Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Biosimilar Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Biosimilar Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Biosimilar Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Biosimilar Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Biosimilar Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Biosimilar Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Biosimilar Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Biosimilar Industry Porter's Five Forces Model Analysis
-
2.2.3 Biosimilar Industry PEST Analysis
-
2.3 Biosimilar Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Biosimilar Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Biosimilar Industry
Chapter 3 Global and China Biosimilar Market, by Manufacturer
-
3.1 Global and China Biosimilar Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Biosimilar Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Biosimilar Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Biosimilar Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Biosimilar Market Top 3 Players
Chapter 4 Global and China Biosimilar Market, by Type (2017-2028)
-
4.1 Biosimilar Market Trend, by Type
-
4.2 Global Biosimilar Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Biosimilar Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Biosimilar Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Biosimilar Price Trend, by Type (2017-2028)
-
4.3 China Biosimilar Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Biosimilar Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Biosimilar Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Biosimilar Price Trend, by Type (2017-2028)
Chapter 5 Global and China Biosimilar Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Biosimilar Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Biosimilar Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Biosimilar Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Biosimilar Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Biosimilar Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Biosimilar Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Biosimilar Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Biosimilar Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Biosimilar Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Biosimilar Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Biosimilar Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Biosimilar Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Biosimilar Market Analysis
-
7.1 North America Biosimilar Market, by Type
-
7.2 North America Biosimilar Market, by Application
-
7.3 North America Biosimilar Market Analysis and Forecast, by Country
-
7.3.1 United States Biosimilar Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Biosimilar Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Biosimilar Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Biosimilar Market Analysis
-
8.1 Europe Biosimilar Market, by Type
-
8.2 Europe Biosimilar Market, by Application
-
8.3 Europe Biosimilar Market Analysis and Forecast, by Country
-
8.3.1 Germany Biosimilar Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Biosimilar Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Biosimilar Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Biosimilar Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Biosimilar Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Biosimilar Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Biosimilar Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Biosimilar Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Biosimilar Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Biosimilar Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Biosimilar Market Analysis
-
9.1 APAC Biosimilar Market, by Type
-
9.2 APAC Biosimilar Market, by Application
-
9.3 APAC Biosimilar Market Analysis and Forecast, by Country
-
9.3.1 China Biosimilar Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Biosimilar Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Biosimilar Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Biosimilar Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Biosimilar Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Biosimilar Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Biosimilar Market Analysis
-
10.1 Latin America, Middle East and Africa Biosimilar Market, by Type
-
10.2 Latin America, Middle East and Africa Biosimilar Market, by Application
-
10.3 Latin America, Middle East and Africa Biosimilar Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Biosimilar Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Biosimilar Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Biosimilar Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Biosimilar Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Biosimilar Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Biosimilar Company Profiles
-
11.1 Novartis
-
11.1.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Novartis Biosimilar Product Profiles, Application and Specification
-
11.1.3 Novartis Biosimilar Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Allergan plc
-
11.2.1 Allergan plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Allergan plc Biosimilar Product Profiles, Application and Specification
-
11.2.3 Allergan plc Biosimilar Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 BIOCAD
-
11.3.1 BIOCAD Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 BIOCAD Biosimilar Product Profiles, Application and Specification
-
11.3.3 BIOCAD Biosimilar Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Coherus BioSciences
-
11.4.1 Coherus BioSciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Coherus BioSciences Biosimilar Product Profiles, Application and Specification
-
11.4.3 Coherus BioSciences Biosimilar Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Reliance Life Sciences
-
11.5.1 Reliance Life Sciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Reliance Life Sciences Biosimilar Product Profiles, Application and Specification
-
11.5.3 Reliance Life Sciences Biosimilar Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Boehringer Ingelheim
-
11.6.1 Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Boehringer Ingelheim Biosimilar Product Profiles, Application and Specification
-
11.6.3 Boehringer Ingelheim Biosimilar Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Pfizer
-
11.7.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Pfizer Biosimilar Product Profiles, Application and Specification
-
11.7.3 Pfizer Biosimilar Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 BioXpress Therapeutics
-
11.8.1 BioXpress Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 BioXpress Therapeutics Biosimilar Product Profiles, Application and Specification
-
11.8.3 BioXpress Therapeutics Biosimilar Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Celltrion
-
11.9.1 Celltrion Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Celltrion Biosimilar Product Profiles, Application and Specification
-
11.9.3 Celltrion Biosimilar Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Biocon
-
11.10.1 Biocon Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Biocon Biosimilar Product Profiles, Application and Specification
-
11.10.3 Biocon Biosimilar Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 Genor BioPharma
-
11.11.1 Genor BioPharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 Genor BioPharma Biosimilar Product Profiles, Application and Specification
-
11.11.3 Genor BioPharma Biosimilar Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 Intas Pharmaceuticals Limited
-
11.12.1 Intas Pharmaceuticals Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 Intas Pharmaceuticals Limited Biosimilar Product Profiles, Application and Specification
-
11.12.3 Intas Pharmaceuticals Limited Biosimilar Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Biosimilar Industry Investment Prospect and Risk Assessment
-
12.1 Biosimilar Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Biosimilar Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Biosimilar Sales Volume and Growth Rate (2017-2028)
-
Figure China Biosimilar Sales Volume and Growth Rate (2017-2028)
-
Figure Global Biosimilar Production Value and Growth Rate (2017-2028)
-
Figure China Biosimilar Production Value and Growth Rate (2017-2028)
-
Figure Global Biosimilar Market Size and Growth Rate of Human Growth Hormones (2017-2028)
-
Figure Global Biosimilar Market Size and Growth Rate of Monoclonal Antibodies (2017-2028)
-
Figure Global Biosimilar Market Size and Growth Rate of Insulin (2017-2028)
-
Figure Global Biosimilar Market Size and Growth Rate of Peptides (2017-2028)
-
Figure Global Biosimilar Market Size and Growth Rate of Erythropoietin (2017-2028)
-
Figure Global Biosimilar Market Size and Growth Rate of Others (2017-2028)
-
Figure Global Biosimilar Market Size and Growth Rate of Oncology (2017-2028)
-
Figure Global Biosimilar Market Size and Growth Rate of Chronic and Autoimmune Diseases (2017-2028)
-
Figure Global Biosimilar Market Size and Growth Rate of Growth Hormone Deficiency (2017-2028)
-
Figure Global Biosimilar Market Size and Growth Rate of Infectious Diseases (2017-2028)
-
Figure Global Biosimilar Market Size and Growth Rate of Others (2017-2028)
-
Figure North America Biosimilar Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Biosimilar Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Biosimilar Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Biosimilar Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Biosimilar Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Biosimilar Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Biosimilar Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Biosimilar Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Biosimilar Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Biosimilar Market Share, by Manufacturer in 2021
-
Figure Global and China Biosimilar Market Share, by Manufacturer in 2022
-
Table Global Biosimilar Sales Volume, by Type (2017-2028)
-
Table Global Biosimilar Sales Volume Share, by Type (2017-2028)
-
Figure Global Biosimilar Sales Volume Share, by Type (2017-2028)
-
Table Global Biosimilar Sales Value, by Type (2017-2028)
-
Table Global Biosimilar Sales Value Share, by Type (2017-2028)
-
Figure Global Biosimilar Price Trend, by Type (2017-2028)
-
Table China Biosimilar Sales Volume, by Type (2017-2028)
-
Table China Biosimilar Sales Volume Share, by Type (2017-2028)
-
Figure China Biosimilar Sales Volume Share, by Type (2017-2028)
-
Table China Biosimilar Sales Value, by Type (2017-2028)
-
Table China Biosimilar Sales Value Share, by Type (2017-2028)
-
Figure China Biosimilar Price Trend, by Type (2017-2028)
-
Table Global Biosimilar Sales Volume, by Application (2017-2028)
-
Table Global Biosimilar Sales Volume Share, by Application (2017-2028)
-
Figure Global Biosimilar Sales Volume Share, by Application (2017-2028)
-
Table Global Biosimilar Sales Value, by Application (2017-2028)
-
Table Global Biosimilar Sales Value Share, by Application (2017-2028)
-
Figure Global Biosimilar Sales Value Share, by Application (2017-2028)
-
Table China Biosimilar Sales Volume, by Application (2017-2028)
-
Table China Biosimilar Sales Volume Share, by Application (2017-2028)
-
Figure China Biosimilar Sales Volume Share, by Application (2017-2028)
-
Table China Biosimilar Sales Value, by Application (2017-2028)
-
Table China Biosimilar Sales Value Share, by Application (2017-2028)
-
Figure China Biosimilar Sales Value Share, by Application (2017-2028)
-
Figure China Biosimilar Production, Import, Consumption and Export (2017-2022)
-
Figure North America Biosimilar Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Biosimilar Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Biosimilar Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Biosimilar Production, Import, Consumption and Export (2017-2022)
-
Table North America Biosimilar Sales Volume, by Type (2017-2028)
-
Table North America Biosimilar Sales Volume Share, by Type (2017-2028)
-
Figure North America Biosimilar Sales Volume Share, by Type (2017-2028)
-
Table North America Biosimilar Sales Volume, by Application (2017-2028)
-
Table North America Biosimilar Sales Volume Share, by Application (2017-2028)
-
Figure North America Biosimilar Sales Volume Share, by Application (2017-2028)
-
Figure United States Biosimilar Sales Volume and Growth Rate (2017-2028)
-
Figure United States Biosimilar Sales Value and Growth Rate (2017-2028)
-
Figure Canada Biosimilar Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Biosimilar Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Biosimilar Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Biosimilar Sales Value and Growth Rate (2017-2028)
-
Table Europe Biosimilar Sales Volume, by Type (2017-2028)
-
Table Europe Biosimilar Sales Volume Share, by Type (2017-2028)
-
Figure Europe Biosimilar Sales Volume Share, by Type (2017-2028)
-
Table Europe Biosimilar Sales Volume, by Application (2017-2028)
-
Table Europe Biosimilar Sales Volume Share, by Application (2017-2028)
-
Figure Europe Biosimilar Sales Volume Share, by Application (2017-2028)
-
Figure Germany Biosimilar Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Biosimilar Sales Value and Growth Rate (2017-2028)
-
Figure UK Biosimilar Sales Volume and Growth Rate (2017-2028)
-
Figure UK Biosimilar Sales Value and Growth Rate (2017-2028)
-
Figure France Biosimilar Sales Volume and Growth Rate (2017-2028)
-
Figure France Biosimilar Sales Value and Growth Rate (2017-2028)
-
Figure Italy Biosimilar Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Biosimilar Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Biosimilar Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Biosimilar Sales Value and Growth Rate (2017-2028)
-
Figure Spain Biosimilar Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Biosimilar Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Biosimilar Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Biosimilar Sales Value and Growth Rate (2017-2028)
-
Figure Poland Biosimilar Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Biosimilar Sales Value and Growth Rate (2017-2028)
-
Figure Russia Biosimilar Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Biosimilar Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Biosimilar Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Biosimilar Sales Value and Growth Rate (2017-2028)
-
Table APAC Biosimilar Sales Volume, by Type (2017-2028)
-
Table APAC Biosimilar Sales Volume Share, by Type (2017-2028)
-
Figure APAC Biosimilar Sales Volume Share, by Type (2017-2028)
-
Table APAC Biosimilar Sales Volume, by Application (2017-2028)
-
Table APAC Biosimilar Sales Volume Share, by Application (2017-2028)
-
Figure APAC Biosimilar Sales Volume Share, by Application (2017-2028)
-
Figure China Biosimilar Sales Volume and Growth Rate (2017-2028)
-
Figure China Biosimilar Sales Value and Growth Rate (2017-2028)
-
Figure Japan Biosimilar Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Biosimilar Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Biosimilar Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Biosimilar Sales Value and Growth Rate (2017-2028)
-
Figure India Biosimilar Sales Volume and Growth Rate (2017-2028)
-
Figure India Biosimilar Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Biosimilar Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Biosimilar Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Biosimilar Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Biosimilar Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Biosimilar Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Biosimilar Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Biosimilar Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Biosimilar Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Biosimilar Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Biosimilar Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Biosimilar Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Biosimilar Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Biosimilar Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Biosimilar Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Biosimilar Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Biosimilar Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Biosimilar Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Biosimilar Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Biosimilar Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Biosimilar Sales Value and Growth Rate (2017-2028)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis Biosimilar Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Allergan plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Allergan plc Product Profiles, Application and Specification
-
Table Allergan plc Biosimilar Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table BIOCAD Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table BIOCAD Product Profiles, Application and Specification
-
Table BIOCAD Biosimilar Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Coherus BioSciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Coherus BioSciences Product Profiles, Application and Specification
-
Table Coherus BioSciences Biosimilar Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Reliance Life Sciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Reliance Life Sciences Product Profiles, Application and Specification
-
Table Reliance Life Sciences Biosimilar Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Boehringer Ingelheim Product Profiles, Application and Specification
-
Table Boehringer Ingelheim Biosimilar Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Pfizer Product Profiles, Application and Specification
-
Table Pfizer Biosimilar Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table BioXpress Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table BioXpress Therapeutics Product Profiles, Application and Specification
-
Table BioXpress Therapeutics Biosimilar Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Celltrion Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Celltrion Product Profiles, Application and Specification
-
Table Celltrion Biosimilar Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Biocon Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Biocon Product Profiles, Application and Specification
-
Table Biocon Biosimilar Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Genor BioPharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Genor BioPharma Product Profiles, Application and Specification
-
Table Genor BioPharma Biosimilar Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Intas Pharmaceuticals Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Intas Pharmaceuticals Limited Product Profiles, Application and Specification
-
Table Intas Pharmaceuticals Limited Biosimilar Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
